Global High-density Multiplexed Diagnostic Assays Market 2017-2021

  • ID: 4316441
  • Report
  • Region: Global
  • 89 pages
  • TechNavio
1 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • F. Hoffmann-La Roche
  • GOLD STANDARD DIAGNOSTICS
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

About High Density Multiplexed Diagnostic Assays

A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. It is distinguished from procedures that measure one analyte at a time. The assay is one of the diagnostic procedures performed in the laboratory, pharmacology, molecular biology, and various other medical procedures. Different types of assays are performed for the detection and diagnosis of patient's sample.

The analysts forecast the global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global high density multiplexed diagnostic assays market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche
Other prominent vendors
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • GOLD STANDARD DIAGNOSTICS
  • Hologic
  • Luminex
  • Randox Laboratories
Market drivers
  • Increasing equipment rental agreements
  • For a full, detailed list, view the full report
Market challenges
  • High cost of multiplexed diagnostic assay equipment
  • For a full, detailed list, view the full report
Market trends
  • Introduction of automated multiplexed PCR assays
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • F. Hoffmann-La Roche
  • GOLD STANDARD DIAGNOSTICS
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • High-density multiplexed diagnostic assays (500-10,000 plex)
  • Very high-density multiplexed diagnostic assays (>10,000 plex)
  • Market overview
PART 07: Market segmentation by end-user
  • Market overview
  • Clinical diagnostic laboratories
  • Hospitals and clinics
PART 08: Geographical segmentation
  • High-density multiplexed diagnostic assays market in Americas
  • High-density multiplexed diagnostic assays market in EMEA
  • High-density multiplexed diagnostic assays market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Infectious diseases
  • Oncology
  • Autoimmune diseases
  • Cardiac diseases
  • Allergies
  • Other application areas
  • Market challenges
PART 11: Market trends
  • Introduction of automated multiplexed PCR assays
  • Higher adoption rate of molecular POCT
  • Improved sensitivity for the detection systems
  • Outsourcing from hospitals to reference laboratories
PART 12: Vendor landscape
  • Competitive landscape analysis
PART 13: Key vendor analysis
  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche
  • Key companies to watch
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Various type of multiplex techniques
Exhibit 02: Global multiplexed diagnostic assays market segmentation (%)
Exhibit 03: Global high-density multiplexed diagnostic assays market 2016-2021: Overview
Exhibit 04: Global high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
Exhibit 05: Features and benefits of personalized medicines: Market impact
Exhibit 06: Five forces analysis
Exhibit 07: Global high-density multiplexed diagnostic assays market by product 2016
Exhibit 08: Global high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
Exhibit 09: Global very high-density multiplexed diagnostic assays market 2016-2021 ($ billions)
Exhibit 10: Global high-density multiplexed diagnostic assays: Overview
Exhibit 11: Buying criteria and impact assessment: End-users
Exhibit 12: Global high-density multiplexed diagnostic assays market 2016-2021: Overview
Exhibit 13: High-density multiplexed diagnostic assays market in Americas 2016-2021: Overview
Exhibit 14: High-density multiplexed diagnostic assays market in Americas 2016-2021 ($ billions)
Exhibit 15: Americas: Market metrics in various countries
Exhibit 16: High-density multiplexed diagnostic assays market in EMEA 2016-2021: Overview
Exhibit 17: High-density multiplexed diagnostic assays market in EMEA 2016-2021 ($ billions)
Exhibit 18: EMEA: Market metrics in various countries
Exhibit 19: High-density multiplexed diagnostic assays market in APAC 2016-2021: Overview
Exhibit 20: High-density multiplexed diagnostic assays market in APAC 2016-2021 ($ billions)
Exhibit 21: APAC: Market metrics in various countries
Exhibit 22: Benefits of leasing instruments
Exhibit 23: Application and indications: High-density multiplexed diagnostic assays market 2016-2021
Exhibit 24: Impact assessment of various application areas
Exhibit 25: Competitive structure analysis of global high-density multiplexed diagnostic assays market 2016
Exhibit 26: Competitive landscape analysis of global high-density multiplexed diagnostic assays market 2016
Exhibit 27: Strategic success factors of companies in global high-density multiplexed diagnostic assays market
Exhibit 28: Thermo Fisher Scientific: Key highlights
Exhibit 29: Thermo Fisher Scientific: Strength assessment
Exhibit 30: Thermo Fisher Scientific: Strategy assessment
Exhibit 31: Thermo Fisher Scientific: Opportunity assessment
Exhibit 32: Abbott: Key highlights
Exhibit 33: Abbott: Strength assessment
Exhibit 34: Abbott: Strategy assessment
Exhibit 35: Abbott: Opportunity assessment
Exhibit 36: F. Hoffmann-La Roche: Key highlights
Exhibit 37: F. Hoffmann-La Roche: Strength assessment
Exhibit 38: F. Hoffmann-La Roche: Strategy assessment
Exhibit 39: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 40: bioMérieux: Company assessment
Exhibit 41: Illumina: Company assessment
Exhibit 42: Qiagen: Company assessment
Exhibit 43: Other prominent vendors in global high-density multiplexed diagnostic assays market
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • F. Hoffmann-La Roche
  • GOLD STANDARD DIAGNOSTICS
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

New Report Released: - Global High-Density Multiplexed Diagnostic Assays Market 2017-2021

The author of the report recognizes the following companies as the key players in the global high-density multiplexed diagnostic assays market: Thermo Fisher Scientific, Abbott, and F. Hoffmann-La Roche.

Other Prominent Vendors in the market are: Agilent Technologies, Bio-Rad Laboratories, Erba Diagnostics, GOLD STANDARD DIAGNOSTICS, Hologic, Luminex, and Randox Laboratories.

Commenting on the report, an analyst from the research team said: “One trend in the market is introduction of automated multiplexed PCR assays. There are automated multiplex systems for simultaneously screening hepatitis B virus, hepatitis C virus, and HIV-1 in blood donations. This helps in reduced hands-on time and elimination of errors with high sensitivity and specificity.”

According to the report, one driver in the market is increasing equipment rental agreements. Most of the instruments such as clinical chemistry analyzers, immunochemistry analyzers, and multiplexed diagnostic equipment used in the IVD market are provided for rental or lease to the end-users. They need to pay for the initial installations and consumables. Leasing the high-cost instruments is an effective and convenient purchasing alternative for the end-users with limited budgets.

Further, the report states that one challenge in the market is high cost of multiplexed diagnostic assay equipment. The rise in prevalence of infectious diseases such HIV/acquired immunodeficiency syndrome (AIDS) and Hepatitis B has led to the increased use of high-density multiplexed diagnostic assays for screening of infectious agents. It helps in shortening the turn-around time, as it is highly sensitive. For example, in the case of detection of HIV, NAT screening reduces the turn-around time from 20 days to six days. It also helps in the detection of the low level of viral DNA or RNA present in the blood.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

  • Thermo Fisher Scientific
  • Abbott
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Erba Diagnostics
  • GOLD STANDARD DIAGNOSTICS
  • Hologic
  • Luminex
  • Randox Laboratories
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll